Business

Wanda Forms Scientific Advisory Board

Wanda Forms Scientific Advisory Board.

articleEmv Capital PlcMarch 16, 20163/company/emv-capital-plc/news/wanda-forms-scientific-advisory-board
Wanda Forms Scientific Advisory Board

About this update from Emv Capital Plc

[{"type":"text","content":"\n \nRNS Number : 2148S NetScientific PLC 16 March 2016  \n\n \n \n (\"NetScientific\" or the \"Group\")\n \n \nWanda Forms Scientific Advisory Board to Provide Strategic Guidance\nLondon, UK - 16 March 2016 - NetScientific plc (AIM: NSCI), the transatlantic biomedical and healthcare technology group, notes its Digital Health Portfolio company, Wanda, has announced the formation of a Scientific Advisory Board to provide thought leadership and strategic guidance to the Wanda management team. Board members include distinguished physicians, health economics scientists, and technologists committed to advancing clinical outcomes for individuals with chronic disease.\nCommenting on the news, NetScientific's Chief Executive Officer, Francois R. Martelet said: \"Wanda's technology has broad potential to simplify and improve the lives of people confronted with chronic conditions and, in the near term, to help patients with Congestive Heart Failure and their physicians to monitor risk and predict and prevent readmission to hospital.  The calibre of the new SAB members is testament to the quality of the Wanda platform and we look forward to their input as Wanda develops into a world-leading digital health business.\"\nThe full text of the announcement issued by Wanda on 15 March 2016 can be found below:\n \nWanda Forms Scientific Advisory Board to Provide Strategic Guidance\n \nInaugural Members include clinical and technology experts committed to advancing the management of chronic disease\n \nSAN FRANCISCO - March 15, 2016 Wanda today announced the formation of a Scientific Advisory Board to provide thought leadership and strategic guidance to the Wanda management team. Board members include distinguished physicians, health economics scientists, and technologists committed to advancing clinical outcomes for individuals with chronic disease.\n \n\"The inaugural members of Wanda's Scientific Advisory Board include an impressive mix of visionaries and opinion leaders across a variety of disciplines,\" said Wanda CCO Mark Heinemeyer. \"All are passionate about advancing state-of-the-art chronic disease management.\"  \n \n\"This group shares Wanda's belief in the power of excellent design to improve connections with patients, to engage loved ones, and to enhance outcomes,\...

More updates from Emv Capital Plc